Vedolizumab is safe and effective in moderate‐to‐severe inflammatory bowel disease following liver transplantation Article Swipe
Related Concepts
Vedolizumab
Medicine
Liver transplantation
Wright
Inflammatory bowel disease
Transplantation
Internal medicine
Gastroenterology
Disease
Art
Art history
Andrew Wright
,
Robert J. Fontana
,
Ryan W. Stidham
·
YOU?
·
· 2017
· Open Access
·
· DOI: https://doi.org/10.1002/lt.24757
· OA: W2596217527
YOU?
·
· 2017
· Open Access
·
· DOI: https://doi.org/10.1002/lt.24757
· OA: W2596217527
Wright, Andrew P. M.D; Fontana, Robert J. M.D; Stidham, Ryan W. M.D., M.S Author Information
Related Topics
Finding more related topics…